Infusion reaction
WikiDoc Resources for Infusion reaction |
Articles |
---|
Most recent articles on Infusion reaction Most cited articles on Infusion reaction |
Media |
Powerpoint slides on Infusion reaction |
Evidence Based Medicine |
Cochrane Collaboration on Infusion reaction |
Clinical Trials |
Ongoing Trials on Infusion reaction at Clinical Trials.gov Trial results on Infusion reaction Clinical Trials on Infusion reaction at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Infusion reaction NICE Guidance on Infusion reaction
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Infusion reaction Discussion groups on Infusion reaction Patient Handouts on Infusion reaction Directions to Hospitals Treating Infusion reaction Risk calculators and risk factors for Infusion reaction
|
Healthcare Provider Resources |
Causes & Risk Factors for Infusion reaction |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: acute infusion reaction; infusion-related reaction
Overview
Infusion reactions is defined as a reaction to the infusion of pharmacological or biological substances. Symptoms may appear within minutes to hours following the infusion and may include pruritus, flushing, swelling, dyspnea, bronchospasm, and hypotension.[1]
Classification
Common Terminology Criteria for Adverse Events (CTCAE) Grade
“ |
CTCAE Grade 1 Cytokine Release Syndrome or Acute Infusion ReactionMild reaction; infusion interruption not indicated; intervention not indicated. CTCAE Grade 2 Cytokine Release Syndrome or Acute Infusion ReactionRequires therapy or infusion interruption but responds promptly to symptomatic treatment (e.g., antihistamines, NSAIDS, narcotics, IV fluids); prophylactic medications indicated for ≤24 hrs. CTCAE Grade 3 Cytokine Release Syndrome or Acute Infusion ReactionProlonged (i.e., not rapidly responsive to symptomatic medication and/or brief interruption of infusion); recurrence of symptoms following initial improvement; hospitalization indicated for other clinical sequelae (e.g., renal impairment, pulmonary infiltrates). CTCAE Grade 4 Cytokine Release Syndrome or Acute Infusion ReactionLife-threatening; pressor or ventilatory support indicated. CTCAE Grade 5 Cytokine Release Syndrome or Acute Infusion ReactionDeath. |
” |
Causes
Common Causes
Causes by Organ System
Cardiovascular | No underlying causes |
Chemical / poisoning | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect |
Denileukin diftitox, galsulfase, Ibritumomab tiuxetan, Pegloticase |
Ear Nose Throat | No underlying causes |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | No underlying causes |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal / Ortho | No underlying causes |
Neurologic | No underlying causes |
Nutritional / Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | No underlying causes |
Opthalmologic | No underlying causes |
Overdose / Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal / Electrolyte | No underlying causes |
Rheum / Immune / Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Dental | No underlying causes |
Miscellaneous | No underlying causes |
Causes in Alphabetical Order
Diagnosis
Signs and Symptoms
- Flushing
- Itching
- Alterations in heart rate and blood pressure
- Dyspnea or chest discomfort
- Back or abdominal pain
- Fever and/or shaking chills
- Nausea, vomiting, and/or diarrhea
- Various types of skin rashes
- Throat tightening
- Hypoxia
- Seizures
- Dizziness and/or syncope
- Signs and symptoms of anaphylaxis